Solid Biosciences (SLDB) Treasury Shares (2018 - 2026)

Solid Biosciences (SLDB) has 9 years of Treasury Shares data on file, last reported at $5.3 million in Q1 2026.

• For the quarter ending Q1 2026, Treasury Shares rose 67.4% year-over-year to $5.3 million; the trailing twelve-month figure through Mar 2026 stood at $5.3 million (up 67.4% YoY), and the FY2025 full-year result was $3.8 million, up 75.94% from the prior year.
• Treasury Shares climbed to $5.3 million in Q1 2026, from $3.8 million in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $5.3 million in Q1 2026 to a low of $512557.0 in Q4 2022.
• A 5-year average of $2.5 million and a median of $2.3 million in 2024 frame the typical range for Treasury Shares.
• Across the five-year window, Treasury Shares jumped 1408.41% in 2022 and surged 67.4% in 2026, its largest moves.
• Tracing SLDB's Treasury Shares over 5 years: stood at $512557.0 in 2022, then surged by 71.14% to $877181.0 in 2023, then soared by 68.75% to $1.5 million in 2024, then jumped by 157.37% to $3.8 million in 2025, then jumped by 39.5% to $5.3 million in 2026.
• Business Quant data shows SLDB's Treasury Shares at $5.3 million in Q1 2026, $3.8 million in Q4 2025, and $3.8 million in Q3 2025.